Other
Sales of and distributions from equity method investments
Medtronic Sales of and distributions from equity method investments decreased by 22.2% to $21.00M in Q4 2025 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ3 2025
Last reportedQ3 2026Feb 24, 2026
How to read this metric
Higher proceeds suggest successful asset rotation or strategic exit from partnerships, providing liquidity for other investments.
Detailed definition
Cash inflows resulting from the divestiture or liquidation of interests in entities accounted for under the equity metho...
Peer comparison
Standard for midstream companies that frequently utilize joint ventures for large-scale infrastructure projects.
Metric ID:
other_proceeds_from_sale_of_equity_method_investmentsHistorical Data
2 periods
| Q3 '25 | Q3 '26 | |
|---|---|---|
| Value | $27.00M | $21.00M |
| QoQ Change | — | -22.2% |
| YoY Change | — | -22.2% |
Range$21.00M – $27.00M
Avg YoY Growth-22.2%
Median YoY Growth-22.2%
Sales of and distributions from equity method investments at Other Companies
Frequently Asked Questions
- What is Medtronic's sales of and distributions from equity method investments?
- Medtronic (MDT) reported sales of and distributions from equity method investments of $21.00M in Q4 2025.
- What does sales of and distributions from equity method investments mean?
- Cash received from selling stakes in companies where the firm holds significant influence.